• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Acute tumor lysis syndrome after rituximab administration in Burkitt's lymphoma.

作者信息

Otrock Zaher K, Hatoum Hassan A, Salem Ziad M

出版信息

Intern Emerg Med. 2008 Jun;3(2):161-3. doi: 10.1007/s11739-008-0099-1. Epub 2008 Feb 13.

DOI:10.1007/s11739-008-0099-1
PMID:18270789
Abstract
摘要

相似文献

1
Acute tumor lysis syndrome after rituximab administration in Burkitt's lymphoma.在伯基特淋巴瘤患者中使用利妥昔单抗后发生的急性肿瘤溶解综合征。
Intern Emerg Med. 2008 Jun;3(2):161-3. doi: 10.1007/s11739-008-0099-1. Epub 2008 Feb 13.
2
[Acute tumor lysis syndrome (ATLS) during remission induction treatment of Burkitt's lymphoma: study of 26 patients].[伯基特淋巴瘤缓解诱导治疗期间的急性肿瘤溶解综合征（ATLS）：26例患者的研究]
An Esp Pediatr. 1988 Oct;29 Suppl 34:109-12.
3
Durable remission induced by rituximab-containing chemotherapy in a patient with primary refractory Burkitt's lymphoma.
Ann Hematol. 2004 Feb;83(2):120-3. doi: 10.1007/s00277-003-0758-2. Epub 2003 Sep 26.
4
Conventional dose intensive immunochemotherapy regimen in an adult patient with very late relapse of Burkitt's lymphoma.一名成年伯基特淋巴瘤极晚期复发患者的常规剂量强化免疫化疗方案
J Chemother. 2007 Apr;19(2):236-8. doi: 10.1179/joc.2007.19.2.236.
5
Acute tumor lysis syndrome induced by rituximab in diffuse large B-cell lymphoma.利妥昔单抗诱发弥漫性大B细胞淋巴瘤急性肿瘤溶解综合征
Int J Hematol. 2005 Nov;82(4):312-4. doi: 10.1532/IJH97.NA0504.
6
Case report: acute tumour lysis syndrome.
Ann Acad Med Singap. 2001 Jan;30(1):55-7.
7
Tumor lysis syndrome occurring after the administration of rituximab in lymphoproliferative disorders: high-grade non-Hodgkin's lymphoma and chronic lymphocytic leukemia.利妥昔单抗用于淋巴增殖性疾病（高度恶性非霍奇金淋巴瘤和慢性淋巴细胞白血病）治疗后发生的肿瘤溶解综合征
Am J Hematol. 1999 Dec;62(4):247-50. doi: 10.1002/(sici)1096-8652(199912)62:4<247::aid-ajh9>3.0.co;2-t.
8
A case report of fatal tumor lysis syndrome after chemotherapy in a pregnant patient with Burkitt's lymphoma.一名患有伯基特淋巴瘤的孕妇化疗后发生致命肿瘤溶解综合征的病例报告。
J Obstet Gynaecol Res. 2011 Aug;37(8):1141-4. doi: 10.1111/j.1447-0756.2010.01485.x. Epub 2011 Apr 12.
9
Treatment of Burkitt lymphoma in adults.成人伯基特淋巴瘤的治疗
Expert Rev Anticancer Ther. 2006 Mar;6(3):373-81. doi: 10.1586/14737140.6.3.373.
10
Rituximab combined with autologous peripheral blood stem cell transplantation improve therapeutic effects of chemotherapy in pediatric patients with Burkitt's lymphoma.利妥昔单抗联合自体外周血干细胞移植提高小儿伯基特淋巴瘤化疗疗效。
J Trop Pediatr. 2010 Oct;56(5):337-41. doi: 10.1093/tropej/fmp137. Epub 2010 Jan 11.

引用本文的文献

1
Integrated Cellular and Plasma Proteomics of Contrasting B-cell Cancers Reveals Common, Unique and Systemic Signatures.对比性B细胞癌的整合细胞和血浆蛋白质组学揭示了共同、独特和系统性特征。
Mol Cell Proteomics. 2017 Mar;16(3):386-406. doi: 10.1074/mcp.M116.063511. Epub 2017 Jan 4.
2
The safety and side effects of monoclonal antibodies.单克隆抗体的安全性和副作用。
Nat Rev Drug Discov. 2010 Apr;9(4):325-38. doi: 10.1038/nrd3003. Epub 2010 Mar 22.

本文引用的文献

1
Rituximab: Mechanism of action and resistance.利妥昔单抗：作用机制与耐药性。
Semin Oncol. 2002 Feb;29(1S2):2-9. doi: 10.1053/sonc.2002.30156.
2
Acute tumor lysis syndrome induced by rituximab in diffuse large B-cell lymphoma.利妥昔单抗诱发弥漫性大B细胞淋巴瘤急性肿瘤溶解综合征
Int J Hematol. 2005 Nov;82(4):312-4. doi: 10.1532/IJH97.NA0504.
3
Tumour lysis syndrome: new therapeutic strategies and classification.肿瘤溶解综合征：新的治疗策略与分类
Br J Haematol. 2004 Oct;127(1):3-11. doi: 10.1111/j.1365-2141.2004.05094.x.
4
Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome.肿瘤溶解综合征的病理生理学、临床后果及治疗
Am J Med. 2004 Apr 15;116(8):546-54. doi: 10.1016/j.amjmed.2003.09.045.
5
Rituximab in B-cell chronic lymphocytic leukemia.利妥昔单抗治疗B细胞慢性淋巴细胞白血病
Semin Oncol. 2003 Aug;30(4):483-92. doi: 10.1016/s0093-7754(03)00239-2.
6
Acute tumor lysis syndrome in large B-cell non-Hodgkin lymphoma induced by steroids and anti-CD 20.
Hematol J. 2003;4(3):222-4. doi: 10.1038/sj.thj.6200244.
7
Dexamethazone-induced acute tumor lysis syndrome in a T-cell malignant lymphoma.地塞米松诱发的T细胞恶性淋巴瘤急性肿瘤溶解综合征
Leuk Lymphoma. 2002 May;43(5):1129-32. doi: 10.1080/10428190290021452.
8
Tumor necrosis factor alpha release is a major biological event associated with rituximab treatment.
Hematol J. 2001;2(6):378-84. doi: 10.1038/sj.thj.6200133.
9
Tumor lysis syndrome occurring after the administration of rituximab in lymphoproliferative disorders: high-grade non-Hodgkin's lymphoma and chronic lymphocytic leukemia.利妥昔单抗用于淋巴增殖性疾病（高度恶性非霍奇金淋巴瘤和慢性淋巴细胞白血病）治疗后发生的肿瘤溶解综合征
Am J Hematol. 1999 Dec;62(4):247-50. doi: 10.1002/(sici)1096-8652(199912)62:4<247::aid-ajh9>3.0.co;2-t.
10
Rapid tumor lysis in a patient with B-cell chronic lymphocytic leukemia and lymphocytosis treated with an anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab).
Ann Hematol. 1998 Jul-Aug;77(1-2):89-91. doi: 10.1007/s002770050419.